InvestSMART

Monash IVF Group Limited (ASX: MVF) - Announcements

Current share price for MVF : $0.715 0.015 (2.05%)+

ASX company news and announcements for Monash IVF Group Limited (MVF) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Monash IVF Group Limited (MVF) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Monash IVF Group Limited (MVF), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Monash IVF Group Limited (MVF)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$279 Dividend/Distribution - MVF 26 Feb 2026 9:16AM $0.690 $0.715 risen by 3.62%
$279 MVF delivers 1H26 Underlying NPAT of $10.4m 26 Feb 2026 9:15AM $0.690 $0.715 risen by 3.62%
$279 1H26 Appendix 4D and Financial Report 26 Feb 2026 9:14AM $0.690 $0.715 risen by 3.62%
$279 FY26 Half Year Results Release 25 Feb 2026 9:13AM $0.700 $0.715 risen by 2.14%
$279 Rebecca Dean appointed Company Secretary & General Counsel 30 Jan 2026 1:00PM $0.705 $0.715 risen by 1.42%
$279 Resignation of Chief Financial Officer 27 Jan 2026 10:58AM $0.750 $0.715 fallen by 4.67%
$279 Initial Director's Interest Notice 6 Jan 2026 12:04PM $0.750 $0.715 fallen by 4.67%
$279 Change of Director's Interest Notice 30 Dec 2025 8:59AM $0.730 $0.715 fallen by 2.05%
$279 NBIO withdrawn to acquire Monash IVF 24 Dec 2025 8:54AM $0.820 $0.715 fallen by 12.80%
$279 CEO and Managing Director commencement date 11 Dec 2025 9:56AM $0.815 $0.715 fallen by 12.27%
$279 MVF 2025 Sustainability Report 2 Dec 2025 1:18PM $0.865 $0.715 fallen by 17.34%
$279 Regulatory Conditions on Victorian ART License Registrations 28 Nov 2025 8:23AM $0.850 $0.715 fallen by 15.88%
$279 Ceasing to be a substantial holder 25 Nov 2025 4:40PM $0.855 $0.715 fallen by 16.37%
$279 Change in substantial holding from SOL 24 Nov 2025 7:13PM $0.880 $0.715 fallen by 18.75%
$279 Notification of Release of Restricted Shares in Escrow 24 Nov 2025 12:15PM $0.850 $0.715 fallen by 15.88%
$279 Initial Director's Interest Notice - Dwayne Crombie 24 Nov 2025 12:15PM $0.850 $0.715 fallen by 15.88%
$279 Becoming a substantial holder 24 Nov 2025 9:37AM $0.610 $0.715 risen by 17.21%
$279 Monash IVF rejects NBIO proposal to acquire MVF 24 Nov 2025 8:46AM $0.610 $0.715 risen by 17.21%
$279 Notification regarding unquoted securities - MVF 24 Nov 2025 8:15AM $0.610 $0.715 risen by 17.21%
$279 Results of Meeting 20 Nov 2025 4:38PM $0.620 $0.715 risen by 15.32%
$279 2025 AGM - Investor Presentation 20 Nov 2025 1:36PM $0.630 $0.715 risen by 13.49%
$279 2025 AGM - Chair Address 20 Nov 2025 1:35PM $0.630 $0.715 risen by 13.49%
$279 Appointment of Chief Executive Officer and Managing Director 11 Nov 2025 11:56AM $0.670 $0.715 risen by 6.72%
$279 Non-executive Director Appointment - Mr Dwayne Crombie 6 Nov 2025 8:33AM $0.670 $0.715 risen by 6.72%
$279 Notice of 2025 Annual General Meeting and Proxy Form 20 Oct 2025 9:15AM $0.715 $0.715 fallen by 0%

26 - 50 of 502 results

Page 2 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.